1. Home
  2. ARBEW vs BDTX Comparison

ARBEW vs BDTX Comparison

Compare ARBEW & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbe Robotics Ltd. Warrant

ARBEW

Arbe Robotics Ltd. Warrant

N/A

Current Price

$0.02

Market Cap

0.0

Sector

Technology

ML Signal

N/A

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$2.02

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARBEW
BDTX
Founded
2015
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
171.9M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ARBEW
BDTX
Price
$0.02
$2.02
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$9.67
AVG Volume (30 Days)
64.3K
487.0K
Earning Date
03-05-2025
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
130.71
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$1.60
52 Week High
$0.50
$4.94

Technical Indicators

Market Signals
Indicator
ARBEW
BDTX
Relative Strength Index (RSI) 50.60 41.85
Support Level $0.02 $1.61
Resistance Level $0.04 $2.28
Average True Range (ATR) 0.01 0.10
MACD 0.00 -0.03
Stochastic Oscillator 26.92 3.75

Price Performance

Historical Comparison
ARBEW
BDTX

About ARBEW Arbe Robotics Ltd. Warrant

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles, as well as for non-automotive uses. Geographically, the company generates maximum revenue from Sweden, and the rest from China, Hong Kong, the USA, Germany, Israel, and other markets.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Share on Social Networks: